Learn how artificial intelligence is used to design AI antibodies, marking a milestone in protein design and treatment innovation.

Explore drug development for obesity and its focus on long-term weight management beyond just rapid loss for effective ...

Biohub have launched a new AI-powered biology initiative, aiming to accelerate scientific discovery and drug development.

Explore how Alzheimer's fat tissue affects metabolism and contributes to heart and metabolic disorders in groundbreaking ...

Learn how FSP1 protein helps metastatic melanoma cells survive and its potential in developing new cancer therapies.

Explore stroke and preeclampsia treatment advancements with DiaMedica's lead drug candidate DM199 and its impact on vascular ...

Explore RNA folding and its significance in RNA-based therapeutics. Discover new insights from Japanese researchers on RNA ...

Learn about the advancements showcased at ELRIG’s Drug Discovery 2025. Discover practical solutions for modern drug research.

Can targeting both regulatory and inflammatory pathways change how we treat neurodegenerative disease? Coya Therapeutics is testing that idea with its IL-2 and GLP-1 receptor agonist combination.

Can targeting both regulatory and inflammatory pathways change how we treat neurodegenerative disease? Coya Therapeutics is testing that idea with its IL-2 and GLP-1 receptor agonist combination.

Explore the link between Alzheimer's progression and the enzyme biliverdin reductase A, which protects neurons from stress.